Incyte Corp.
(NASDAQ : INCY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
2.59%282.271.4%$841.66m
AMGNAmgen, Inc.
1.08%220.861.3%$515.75m
CELGCelgene Corp.
0.00%110.021.3%$466.76m
GILDGilead Sciences, Inc.
1.98%65.071.0%$400.35m
VRTXVertex Pharmaceuticals, Inc.
2.34%209.801.9%$313.89m
ILMNIllumina, Inc.
2.53%305.993.5%$311.32m
REGNRegeneron Pharmaceuticals, Inc.
1.92%344.872.6%$267.68m
EXASEXACT Sciences Corp.
3.55%82.0524.0%$209.78m
ALXNAlexion Pharmaceuticals, Inc.
2.34%108.372.0%$179.80m
SGENSeattle Genetics, Inc.
1.29%114.756.1%$136.96m
BMRNBioMarin Pharmaceutical, Inc.
-0.71%75.044.3%$123.64m
SRPTSarepta Therapeutics, Inc.
0.05%97.4614.6%$115.38m
AAgilent Technologies, Inc.
1.95%78.261.6%$101.36m
NBIXNeurocrine Biosciences, Inc.
2.89%113.055.0%$90.40m
BGNEBeiGene Ltd.
0.94%198.252.1%$88.64m

Company Profile

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.